We present and discuss several methods for analyzing rodent tumorigenicity experiments. Two approaches are based on the age and tumor status (present/absent) of each animal at the time of death, and assume either that the tumor type is nonlethal or instantly lethal. Two other approaches avoid such restrictive assumptions about tumor lethality by requiring additional types of data. One method assumes that animals are randomly sacrificed at various ages throughout the study. The second approach requires that each animal which develops the tumor be classified as dying either from the tumor or from other causes
This paper considers the use of historical control data in the evaluation of tumor incidences from c...
An index of carcinogenic potency for chemicals tested in chronic animal experiments is described. By...
This paper considers the impacts of various patterns of differential or excess mortality on the biol...
This document describes many of the statistical approaches that are being used to analyze data from ...
The statistical interpretation of long-term animal carcinogenesis experiments seems complicated at f...
The two-year cancer bioassay in rodents remains the primary testing strategy for in-life screening o...
Researchers routinely use historical control data (HCD) when analyzing rodent carcinogenicity data o...
Due to the occult nature of tumors observed in animal carcinogenicity experiments, information about...
We are refemng in this paper to traditional tests of genotoxicity that are essentially detecting pro...
In animal carcinogenicity experiments, 50 to 100 animals per dose are treated with a potential carci...
In an earlier report we developed a quantitative likelihood-based analysis of the differences in sen...
Anticarcinogenicity in a long-term rodent bioassay is defined as a statistically significant decreas...
<p>4–5 animals examined per group. All selected mutant mice are at end of life, wild type mice are a...
A mutation in the Apc gene leads to early spontaneous development of intestinal cancer in mice. The ...
In animal tumorigenicity data, the time of occurrence of the tumor is not observed because the exist...
This paper considers the use of historical control data in the evaluation of tumor incidences from c...
An index of carcinogenic potency for chemicals tested in chronic animal experiments is described. By...
This paper considers the impacts of various patterns of differential or excess mortality on the biol...
This document describes many of the statistical approaches that are being used to analyze data from ...
The statistical interpretation of long-term animal carcinogenesis experiments seems complicated at f...
The two-year cancer bioassay in rodents remains the primary testing strategy for in-life screening o...
Researchers routinely use historical control data (HCD) when analyzing rodent carcinogenicity data o...
Due to the occult nature of tumors observed in animal carcinogenicity experiments, information about...
We are refemng in this paper to traditional tests of genotoxicity that are essentially detecting pro...
In animal carcinogenicity experiments, 50 to 100 animals per dose are treated with a potential carci...
In an earlier report we developed a quantitative likelihood-based analysis of the differences in sen...
Anticarcinogenicity in a long-term rodent bioassay is defined as a statistically significant decreas...
<p>4–5 animals examined per group. All selected mutant mice are at end of life, wild type mice are a...
A mutation in the Apc gene leads to early spontaneous development of intestinal cancer in mice. The ...
In animal tumorigenicity data, the time of occurrence of the tumor is not observed because the exist...
This paper considers the use of historical control data in the evaluation of tumor incidences from c...
An index of carcinogenic potency for chemicals tested in chronic animal experiments is described. By...
This paper considers the impacts of various patterns of differential or excess mortality on the biol...